Navigation Links
The Wistar Institute collaborates with the Coriell Institute to distribute cell lines

(PHILADELPHIA) Cell lines developed by scientists at The Wistar Institute in Philadelphia have recently been made available to researchers around the globe through the catalog collection at the Coriell Institute for Medical Research of Camden, N.J.

The collaboration means that scientists at a variety of research organizations can access biological materials developed at Wistar for use in the development of vaccines and treatments for cancer and other deadly diseases.

We are pleased to make these valuable materials widely available to the research community through the Coriell Biobank, said Russel E. Kaufman, M.D., president and CEO of Wistar. This collaboration with Coriell, who is a leader in the storage and distribution of biological materials, means that some of the key tools used in the potentially lifesaving work of Wistar scientists will be made available worldwide.

The initial Wistar collection to be distributed by Coriell includes hybridoma cell lines that produce monoclonal antibodies that measure peoples exposure to influenza viruses and response to vaccines. These cell lines were developed over the course of 30 years by renowned influenza researcher Walter Gerhard, M.D., who retired from Wistar in 2007. The monoclonal antibodies produced by these cell lines are useful in the development of vaccines against a variety of influenza strains, including pandemic influenza, Kaufman said.

Wistar and Coriell also are working to add melanoma cell lines developed in the laboratory of Wistar researcher Meenhard Herlyn, D.V.M., D.Sc., to the Wistar collection at Coriell. Cell lines amassed by Herlyn represent one of the most comprehensive melanoma cell line collections in the world, Kaufman said, and may be useful in developing drugs to treat melanoma and other cancers.

Coriell is pleased to partner with The Wistar Institute and bring together the knowledge, talents and vision of two established institutions that are international leaders in basic biomedical research, said Michael Christman, Ph.D., president and CEO of The Coriell Institute. Through this partnership we will further expand the distribution of cell lines to researchers who are working to discover cures for diseases and improve healthcare worldwide.

Our hope is that this new partnership to house and distribute these cell lines is only the beginning of further collaborative work to support biomedical research and improved public health.


Contact: Abbey J. Porter
The Wistar Institute

Related medicine news :

1. Novel vaccine concept developed by scientists at the Wistar Institute
2. The Risk Management and Patient Safety Institute Announces Annual Health Care Risk Conference Dates
3. Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute
4. LifeNet Health Establishes The Skin & Wound Allograft Institute
5. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
6. CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health
7. Portico Systems to Share Provider Network Management Best Practices at Institute for International Research
8. The Integrated Benefits Institute Offers Largest Benchmarking Database in U.S. Spanning Disability and Workers Compensation Programs
9. The Cooper Institutes FITNESSGRAM Selected as Statewide Physical Fitness Assessment Tool
10. Bullying Prevention Institute Designed to Empower Change in Schools
11. Southern Research Institutes Neurodegenerative Disease Drug Discovery Program Receives National Institute of Mental Health Funding
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., ... the 61st annual Employee Benefits Conference. The Employee Benefits Conference was hosted by ... through Wednesday, November 11th, 2015. The conference was held at the Hawaii Convention ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of ... server to improve system efficiency and reliability. , The new Q-Suite 6 platform is ... the system avoids locking itself into a specific piece of software for many key ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... preparing the perfect dish and pleasing the palates of attendees is of the ... a dish to a seasonal get-together, give these recipes a try this holiday ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... offering factory direct sauna parts and accessories. , Sauna accessories help improve the ... bather’s style and personality. From basic styles for the purist looking for simplicity ...
(Date:11/25/2015)... ... ... On November 10, 2015, Bohrer Brady, LLC filed a class and collective ... home health care worker who provided companionship services for the elderly, ill or disabled ... Humana, Inc., Humana at Home, Inc., and SeniorBridge Family Companies (CT), Inc. since January ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
(Date:11/25/2015)... -- On Tuesday, November 24, 2015, the jury ... Medical Technology, Inc. for product liability and misrepresentation ... device, awarded $11 million in favor of Plaintiff ... three days of deliberations, the jury found that ... and unreasonably dangerous, and that Wright Medical made ...
(Date:11/25/2015)... Nov. 25, 2015 Allergan plc (NYSE: AGN ... the New York State Attorney General,s ... Sherman Act, and other statutes with the Attorney General over ... to cease marketing and selling the now generic version of ... admits no liability, has released its counterclaims against ...
Breaking Medicine Technology: